EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1

Yalei Wen, Xiao Yang, Shengrong Li, Lei Huang, Jiayi Chen, Lirong Tan, Xiuqing Ma, Yingjie Zhu, Zhengqiu Li, Changliang Shan iD, Chunze Zhang, Qiushi Zhang und 3 weitere

MedComm · 2025-03 · 6 (3)

DOI: 10.1002/mco2.70103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm, online erschienen am 17.02.2025. Verfasst von Yalei Wen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Maternal and Child Health, The Affiliated Guangdong Second Provincial General Hospital, Postdoctoral Research Station of Tradi…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is among the most prevalent and deadly cancers worldwide. The Yes‐associated protein 1 (YAP1) is frequently dysregulated in cancers, contributing to cancer stemness, chemoresistance, and cancer‐related death. However, strategies directly targeting YAP1 have not yet been successful because of the lack of active binding pockets and unregulated toxicity. In this study, our Food and Drug Administration (FDA)‐approved drug screening reveals that abemaciclib, a cyclin‐dependent kinase 4/6 (CDK4/6) inhibitor, dramatically promotes the proteasome‐dependent degradation of YAP1, thereby inhibiting tumor progression in CRC cells and patient‐derived xenograft models. We further identify deubiquitinating enzyme 3 (DUB3) as the bona fide deubiquitinase of YAP1 in CRC. Mechanistically, CDK4/6 directly phosphorylates DUB3 at Ser41, activating DUB3 to deubiquitinate and stabilize YAP1. Conversely, loss of Ser41 phosphorylation by CDK4/6 inhibition or Ser41A mutation, promotes YAP1 degradation and suppresses YAP1‐driven tumor progression. Histological analysis shows a positive correlation between DUB3 and YAP1 expression in CRC specimens. Collectively, our study uncovers a novel oncogenic role of the CDK4/6‐DUB3 pathway, which promotes YAP1 stabilization and tumor‐promoting function, highlighting that targeting CDK4/6 offers a potential therapeutic strategy for CRC with aberrantly upregulated DUB3 and YAP1.

Schlagwörter

Stichwörter der Autor:innen

Yes‐associated protein 1 (YAP1)abemaciclibcolorectal cancer (CRC)cyclin‐dependent kinase 4/6 (CDK4/6)deubiquitinating enzyme 3 (DUB3)

Autor:innen und Institutionen

  • Research Institute for Maternal and Child Health, The Affiliated Guangdong Second Provincial General Hospital, Postdoctoral Research Station of Traditional Chinese Medicine, School of Pharmacy Jinan University Guangzhou…
  • State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) o…
  • State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research Nankai University Tianjin China.
  • Department of Colorectal Surgery, Tianjin Union Medical Center Nankai University Tianjin China.
  • Research Institute for Maternal and Child Health, The Affiliated Guangdong Second Provincial General Hospital Jinan University Guangzhou China.
  • The Affiliated Shunde Hospital of Jinan University Foshan China.

ORCID-Profile: Changliang Shan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wen, Y., Yang, X., Li, S., Huang, L., Chen, J., Tan, L., Ma, X., Zhu, Y., Li, Z., Shan, C., Zhang, C., Zhang, Q., Liang, M., Zhang, H., & Liu, T. (2025). Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1. MedComm, 6(3). https://doi.org/10.1002/mco2.70103

Vancouver

Wen Y, Yang X, Li S, Huang L, Chen J, Tan L, et al. Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1. MedComm. 2025;6(3). doi:10.1002/mco2.70103

BibTeX
@article{Wen2025,
  author = {Wen, Yalei and Yang, Xiao and Li, Shengrong and Huang, Lei and Chen, Jiayi and Tan, Lirong and Ma, Xiuqing and Zhu, Yingjie and Li, Zhengqiu and Shan, Changliang and Zhang, Chunze and Zhang, Qiushi and Liang, Mingchao and Zhang, Haoxing and Liu, Tongzheng},
  title = {Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {3},
  doi = {10.1002/mco2.70103}
}
Kostenlos starten →